Global Innovative Platforms Inc. (GIPL)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Operating profit | $m | -1 | -1 | ||||||
| Net profit | $m | -0 | -0 | -0 | -0 | -0 | -1 | -1 | - |
| EPS reported | $ | -0.02 | -0.02 | ||||||
| Operating cashflow per share | $ | -0.01 | -0.01 | ||||||
| Capex per share | $ | 0.00 | 0.00 | ||||||
| FCF per share | $ | -0.01 | -0.01 | ||||||
| Free cash flow | $m | -1 | -0 | ||||||
| Net debt | $m | -0 | -0 | ||||||
| Book value equity | $m | 0 | 1 | ||||||
| Book value per share | $ | 0.00 | 0.01 | ||||||
| Number of shares | m | 39.37 | 48.78 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 23.08 | 8.15 | ||||||
| P/S LTM | x | 0.00 | 23.13 | ||||||
| P/FCF LTM | x | -7.72 | -16.21 | ||||||
| EV/EBITDA LTM | x | -6.01 | -6.50 | ||||||
| EV/Sales LTM | x | 0.00 | 164.24 | ||||||
| Earnings Yield LTM | % | -16.59% | -3.00% | ||||||
| FCF Yield | % | -12.95% | -6.17% | ||||||
| Quality | |||||||||
| ROE | % | -382.73% | -231.52% | ||||||
| ROIC | % | -3.80% | -1.10% | ||||||
| Operating margin | % | 0.00% | -4.74% | ||||||
| Gross margin | % | 0.00% | +86.69% | ||||||
| FCF/Sales | % | - | -282.74% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | - | - | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -373.83 | - | ||||||
| Net Debt/EBITDA | x | 0.02 | 0.52 | ||||||
| EBIT/Net interest | x | 0.00 | 0.00 | ||||||
| Net debt/market cap | % | +0.03% | 0.00% | ||||||
| Net debt/Equity | x | -0.09 | -0.46 | ||||||
| Gross debt/equity | x | 0.01 | 0.00 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was incorporated in 2020 and is based in Sanford, Florida.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Global Innovative Platforms Inc. (GIPL)
No price history available.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. The company develops Heartworm breath test, which includes breath collection device, to collect shallow breath samples. It also operates VOCAM Plus and FROG platform for gas chromatography, as well as operates A.I. software to provide breath and air analysis. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. Global Innovative Platforms Inc. was incorporated in 2020 and is based in Sanford, Florida.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free